Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Keyi Geng

5PUBLICATIONS
50CO-AUTHORS
Epigenetics (incl. genome methylation and epigenomics)Molecular targetsGenome structure and regulationMedical infection agents (incl. prions)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

Sort by Publication Date:
|Nov 20, 2023
Intrinsic deletion at 10q23.31, including the <i>PTEN</i> gene locus, is aggravated upon CRISPR-Cas9-mediated genome engineering in HAP1 cells mimicking cancer profiles.

Keyi Geng, Lara G Merino, Raül G Veiga

|Oct 13, 2023
Coinhibition of topoisomerase 1 and BRD4-mediated pause release selectively kills pancreatic cancer via readthrough transcription.

Donald P Cameron, Jan Grosser, Swetlana Ladigan

|Sep 30, 2022
Target-enriched nanopore sequencing and de novo assembly reveals co-occurrences of complex on-target genomic rearrangements induced by CRISPR-Cas9 in human cells.

Keyi Geng, Lara G Merino, Linda Wedemann

|May 20, 2022
Myeloid cell-specific topoisomerase 1 inhibition using DNA origami mitigates neuroinflammation.

Keying Zhu, Yang Wang, Heela Sarlus

|Jan 13, 2022
CCT3-<i>LINC00326</i> axis regulates hepatocarcinogenic lipid metabolism.

Jonas Nørskov Søndergaard, Christian Sommerauer, Ionut Atanasoai

Pageof 1

Frequent Collaborators

5 joint publications

Claudia Kutter

2 joint publications

Jonas Nørskov Søndergaard

2 joint publications

Christian Sommerauer

2 joint publications

Lara G Merino

1 joint publications

Ionut Atanasoai

1 joint publications

Laura C Hinte

1 joint publications

Giulia Guiducci

1 joint publications

Lars Bräutigam

1 joint publications

Myriam Aouadi

1 joint publications

Lovorka Stojic

Frequent Collaborators

5 joint publications

Claudia Kutter

2 joint publications

Jonas Nørskov Søndergaard

2 joint publications

Christian Sommerauer

2 joint publications

Lara G Merino

Top Related Videos

Electroporation-Based CRISPR-Cas9-Mediated Gene Knockout in THP-1 Cells and Single-Cell Clone Isolation
09:29

Electroporation-Based CRISPR-Cas9-Mediated Gene Knockout in THP-1 Cells and Single-Cell Clone Isolation

Published on : Feb 28, 2025

910
Through the Looking Glass: Time-lapse Microscopy and Longitudinal Tracking of Single Cells to Study Anti-cancer Therapeutics
06:00

Through the Looking Glass: Time-lapse Microscopy and Longitudinal Tracking of Single Cells to Study Anti-cancer Therapeutics

Published on : May 14, 2016

11.1K
A Standard Methodology to Examine On-site Mutagenicity As a Function of Point Mutation Repair Catalyzed by CRISPR/Cas9 and SsODN in Human Cells
10:07

A Standard Methodology to Examine On-site Mutagenicity As a Function of Point Mutation Repair Catalyzed by CRISPR/Cas9 and SsODN in Human Cells

Published on : Aug 25, 2017

7.9K
See more related videos

Top Related Videos

Electroporation-Based CRISPR-Cas9-Mediated Gene Knockout in THP-1 Cells and Single-Cell Clone Isolation
09:29

Electroporation-Based CRISPR-Cas9-Mediated Gene Knockout in THP-1 Cells and Single-Cell Clone Isolation

Published on : Feb 28, 2025

910
Through the Looking Glass: Time-lapse Microscopy and Longitudinal Tracking of Single Cells to Study Anti-cancer Therapeutics
06:00

Through the Looking Glass: Time-lapse Microscopy and Longitudinal Tracking of Single Cells to Study Anti-cancer Therapeutics

Published on : May 14, 2016

11.1K
A Standard Methodology to Examine On-site Mutagenicity As a Function of Point Mutation Repair Catalyzed by CRISPR/Cas9 and SsODN in Human Cells
10:07

A Standard Methodology to Examine On-site Mutagenicity As a Function of Point Mutation Repair Catalyzed by CRISPR/Cas9 and SsODN in Human Cells

Published on : Aug 25, 2017

7.9K
See more related videos